Recent studies have highlighted the synergistic effects of FSH and apolipoprotein E4 (ApoE4) (Xiong et al., 2023a), the primary genetic risk factor for AD, in activating the C/EBPβ/δ-secretase pathway, which promotes AD-like pathologies (Figure 1). The gene discussed is APOE; the disease is Alzheimer disease.